Abstract: A sweetener additive for use with consumable products, such as foods and beverages, to sweeten the consumable product and provide health benefits to a consumer who consumes a consumable product. The sweetener additive has a sweetener base and one or more of selected flavonoids. The sweetener base has one or more sweeteners commonly utilized to sweeten consumable products. The flavonoids may be extracted from plants chosen from the genus Hovenia, such as the Japanese raisin tree. The selected flavonoids provide various health benefits, including stimulating naturally occurring enzymes in the consumer's body. One or more aldehyde reducing enzymes, one or more glucose reducing enzymes and/or one or more alcohol reducing enzymes may be added to the sweetener additive to supplement naturally occurring enzymes in the consumer's body to reduce the deleterious effects of aldehydes, glucose and/or alcohol on the consumer. The flavonoids will also stimulate the added enzymes.

Abstract: The present invention relates to a carrier for facilitating the oral ingestion of at least one active substance by animals, characterized in that it comprises: at least one bead comprising said at least one active substance, a gelled appetizing matrix surrounding said at least one bead, the pH of said matrix being less than 4, wherein the Aw (residual water) of said matrix and of said at least one bead is identical and from 0.4 to 0.9. The present invention also relates to a method for preparing such a carrier, and also to the uses thereof. The present invention also relates to a non-therapeutic method for feeding animals, in particular dogs and cats, by means of this carrier.

Abstract: The invention relates to aboveground plant parts of Sideritis ssp. or extracts produced therefrom for use to boost cognitive performance.

Abstract: The present invention provides compounds isolated from avocado seeds for use as a natural colorant in edible materials. The compounds of the invention are useful for coloring edible materials red, orange, or yellow. The invention also provides compositions and methods for coloring edible materials to a desired color such as red, orange, or yellow.

Abstract: The present invention relates to compositions comprising L-arginine and L-citrulline in specific ratios. In particular, the present invention relates to the use of such compositions for improving sexual function in a healthy human subject.

Abstract: White blood cells and/or neutrophils in a companion animal can be improved by adjusting the diet of the animal to increase the amount of a compound which positively or negatively modulates the white blood cells and/or neutrophils or adjusting the diet of the animal to decrease the amount of a compound which positively or negatively modulates the white blood cells and/or neutrophils.

Abstract: Disclosed herein are dietary supplement compositions and methods for increasing or stimulating bone growth, decreasing or preventing bone resorption, increasing bone strength, improving bone structure, and improving bone architecture comprising a first composition comprising a combination of at least two of: quercetin, Rehmannia sp., Rehmannia sp. root, Siberian ginseng, Sophora japonica, licorice, and ipriflavone, wherein the combination of the first composition increases bone morphogenic protein-2 gene, promoter or protein expression; and a second composition comprising an extract of pomegranate in combination with at least one of Siberian ginseng, Ginkgo biloba, green tea, Sophora japonica, Rehmannia sp., grape seed, Dong Quai, and ipriflavone, wherein the combination of the second composition inhibits the expression of RANK-L.

Abstract: A strawberry plant extract, an extraction method and a novel use thereof are disclosed. The extraction method comprises: darkly incubating a strawberry plant between the anthesis stage and the first harvest stage, harvesting the strawberry plant with the green-white, white or white-red color of the strawberry fruit, and extracting the strawberry plant with ethanol to obtain the strawberry plant extract. The invention further relates to the use of a strawberry plant extract for the manufacture of a composition, wherein the composition is for inhibiting the secretion of cell promoting inflammatory mediators.

Abstract: The invention provides the use of low molecular weight collagen hydrolysate for reducing joint pain such as in arthritis or osteoarthritis.

Abstract: The present invention relates to compositions comprising L-arginine and L-citrulline in specific ratios. In particular, the present invention relates to the use of such compositions for improving sexual function in a healthy human subject.

Abstract: The invention relates to novel genetically modified plants and methods or materials, such as polynucleotides, expression cassettes, or vectors for producing the same. Moreover, the invention relates to altering the content of cannabinoids in plants and to medical compositions derived from such plants. In particular embodiments, the present invention relates to cannabis plants having modified expression of tetrahydrocannabinolic acid (THCA) synthase and methods of modifying the amount of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in cannabis by modifying expression of THCA synthase.

Abstract: The present invention relates to the use of cocoa polyphenols, in particular, procyanidin(s) in the treatment or prevention of eosinophilic esophagitis.

Abstract: The present application concerns compositions comprising ellagitannins and proanthocyanidins, and the use of such compositions for preventing or treating endothelial dysfunction. The compositions of the invention comprise at least one ellagitannin in combination with at least one proanthocyanidin. The present application also concerns methods of treating, preventing, or delaying the onset of endothelial dysfunction using compositions comprising ellagitannins and proanthocyanidins.

Abstract: The present invention relates to compositions and methods for the prevention and treatment of neurodegenerative diseases, such Alzheimer's disease, that are caused by misfolding, aggregating proteins. The compositions and methods of the present invention comprise a vaccine formulation comprising an antigen selected from the group consisting of i) amyloid-? or a peptide that has in its amino acid sequence part of the amyloid-? amino acid sequence, ii) hyperphosphorylated tau protein or one of its hyperphoshorylated peptides, or iii) a combination of antigens derived from groups i) and ii) and that are formulated with a non-acylated or deacylated, natural or synthetic, bidesmosidic triterpene glycoside carrying an aldehyde or ketone group, which acts as an adjuvant or immune agonist. These vaccine formulations are capable of stimulating a Th2 immunity or antibody response against antigens such as amyloid-? and tau derived antigens, but not a Th1 immune response.

Abstract: The present invention relates to epicatechin for use in the prevention or reduction of symptoms of an allergic disorder and/or an allergic reaction. The invention further relates to epicatechin for said use in the form of food, food product, food supplement or pharmaceutical products.

Abstract: Provided is a composition for reducing oxidative stress and/or side effects occurring during cancer chemotherapy or improving a nutritional status during cancer chemotherapy. The composition is one for reducing oxidative stress and/or side effects occurring during cancer chemotherapy or improving nutritional status during cancer chemotherapy and comprises the following components (a) to (f): (a) an antioxidant agent; (b) at least one component selected from the group consisting of vitamin B1, vitamin B2, vitamin B6, niacin, and pantothenic acid; (c) at least one component selected from the group consisting of folic acid, vitamin B12, and vitamin A; (d) zinc; (e) selenium; and (f) coenzyme Q10.

Abstract: A method for reducing human or animal weight from body fat, comprising providing a caloric source having a mild flavor or less flavor, other than sweetness or saltiness, at a time different from meal time and in an amount sufficient to provide a significant fraction of total daily caloric consumption, while eating normal food at meal times.

Abstract: Disclosed is a perfume composition including grapefruit oil and bergamot oil and further including one or more selected from a group consisting of pine oil, lemon oil, cypress oil, rose oil and armoise oil. The perfume composition is useful in the field of beauty care, cosmetics, or the like.

Abstract: An object of the present invention is to provide an agent for promoting proliferation of a meibomian gland epithelial cell and a corneal epithelial cell, as well as provide an agent for treating an ocular disease such as meibomian gland dysfunction or evaporative dry eye. There are provided an agent for promoting proliferation of a meibomian gland epithelial cell or a corneal epithelial cell, containing a PPAR? or ? agonist as an active ingredient, as well as an agent for treating an ocular disease such as meibomian gland dysfunction or evaporative dry eye, containing a PPAR? or ? agonist as an active ingredient.

Abstract: The present invention provides topical compositions, methods of preparation, and methods of treatment for onychomychosis. In certain specific embodiments, the invention provides an anti-fungal pharmaceutical composition for topical application comprising an anti-fungal agent, a zwitterionic surfactant or charged derivative thereof; a carboxylic acid, a lower alcohol, and water. The acid is selected from a short-chain hydroxy acid, a short-chain fatty acid, and a mixture thereof. In certain other specific embodiments, the invention provides an anti-fungal pharmaceutical composition for topical application comprising an anti-fungal agent, a quarternary amino acid, a keratolytic agent; a lower alcohol; and water. In certain embodiments, the keratolytic agent is urea, ammonium thioglycolate, or a mixture thereof.

Abstract: Disclosed are compositions that include Docynia delavajy extract, Elaeagnus lanceolatus extract, or a combination of such extracts.

Abstract: Compositions for reducing the appearance of wrinkles, reducing the effects of aging and/or improving the appearance of skin. The composition may include at least one fluorinated perfluorocarbon; stem cells from at least one plant species; and at least one peptide complex that reduces release of acetylcholine. Other embodied compositions include at least one collagen stimulating peptide; at least one anti-inflammatory compound; and at least one skin tightening agent.

Abstract: The invention relates to a reference plant which has been selected to: a) not express a medicinally active compound or group of compounds; yet b) express, at least substantially qualitatively, most other non medicinally active compounds present in a therapeutically active comparator plant. The reference plant can be used to generate a reference extract with a reference chemical profile which resembles that of the comparator plant less the active compound or group of compounds and may thus be used as a placebo or to otherwise test the hypothesis that the active compound or compounds are responsible for an extracts perceived medicinal activity.

Abstract: Disclosed is a composition which comprises a combination of Aronia extract in an amount of at least about 10 ?g/mg and seleniumin in an amount from about 0.0001 ?g/mg to about 2.0 ?g/mg. The composition may further comprise zinc as additional micronutrient. The composition may be formulated as a pharmaceutical or a nutraceutical composition.

Abstract: The invention relates to improving sexual fitness or wellness of both sexes, the male sexual enhancement, the treatment of sexual dysfunction and the health of the sexual vascular system of both sexes with ingredients that consist in a source of proanthocyanidins, a source of arginine, rose hip extracts and/or Quercus robur extracts. The source of proanthocyanidins may be a botanical extract and the source of arginine may be from arginine aspartate.

Abstract: A Tie2 activator containing, as an active ingredient, a hawthorn extract, a starfruit extract, a shellflower extract, a lotus extract, a rooibos extract, an Indian date extract, a Chinese quince extract, a Psidium guava extract, a long pepper extract, a Quillaja extract, a Kouki extract, a ginkgo extract, an oyster extract, a turmeric extract, a chrysanthemum extract, a jujube extract, a Chinese wolfberry extract, a chamomile extract, or a Butcher's Broom extract, or any combination thereof.

Abstract: A water-soluble anti-inflammatory cream is disclosed. The cream is a composition of between about 7.5% and about 30% by weight of a healing oil; between about 1% and about 6% by weight of an herbal extract; between about 0% and about 3.5% by weight of microencapsulated amino acids; and at least 39.4% by weight water.

Abstract: A disinfectant composition is provided comprising an extract comprising phenolic compounds obtainable from Rubus species berries, at least one surfactant and water. This aqueous solution can be used for disinfecting solid surfaces, especially those, which do not tolerate solvents such as high concentration ethanol or isopropanol, preferably touch screens or touch panels. A wiping article comprising said disinfectant composition is provided as well.

Abstract: The present invention relates to a mixture, having a skin-tightening effect, which is made up of: 10 to 80% by weight of a polysaccharide, preferably of an alginate, having a molecular weight of less than 600,000 Daltons, preferably less than 400,000 Daltons and more preferably less than 200,000 Daltons, 15 to 75% by weight of a polyhydroxylated agent selected from sugars and their derivatives, particularly sugar esters and sugar, ethers, preferably sorbitol, 3 to 15% by weight of poly(vinyl alcohol) or polyvinylpyrrolidone, and 0 to 25% by weight of cellulose or of a derivative of cellulose, such as carboxymethylcellulose or hydroxymethylcellulose. The present invention also relates to cosmetic compositions which contain this mixture. These cosmetic compositions enable a mechanical smoothing of the surface of the skin to be obtained progressively with great comfort of use and enables a good fixing of make-up products.

Abstract: The present invention relates to a composition comprising an NF?B-inhibitor and a tropoelastin promoter, and methods of treating signs of skin aging using said compositions.

Abstract: Compositions and methods for inducing hair growth and improving hair quality utilizing extracts of blackberry in an amount effective to induce hair growth when applied topically to an area of the skin on which hair growth is desired.

Abstract: A composition for inhibiting ketohexokinase, for example, ketohexokinase-C (KHK-C) activity, may include a plant extract exhibiting at least IC50 (i.e., 50% KHK-C inhibition at a concentration in the range of from about 0.1 ?g/mL to about 1000 ?g/mL. The composition may be in a form suitable for oral ingestion. A method for inhibiting KHK-C activity in a subject may include administering a plant extract that exhibits at least 50% KHK-C inhibition at a concentration from about 0.1 ?g/mL to about 1000 ?g/mL. The administering may be done to treat or prevent at least one of sugar addiction, obesity, or metabolic syndrome. The administering may be done to provide a diminished craving in the subject from at least one member selected from the group consisting of craving of sugar, fructose, fructose-containing sugars, carbohydrates, and combinations thereof. The subject may be pre-diabetic, diabetic and or insulin resistant.

Abstract: The present invention relates to a pharmaceutical composition for preventing or treating Parkinson's disease, which comprises, as an active ingredient, a Rhodotypos scandens extract obtained by extracting the stem of Rhodotypos scandens with an organic solvent, and a food additive showing the effect of preventing or treating Parkinson's disease, the food additive comprising Rhodotypos scandens extract as an active ingredient. The Rhodotypos scandens extracts of the present invention may prevent or treat Parkinson's disease without producing any particular side effects, and therefore can be widely used for more safely treating Parkinson's disease.

Abstract: A cosmetic product having a pH value of 3.0 to 5.2 is disclosed that is specifically suitable for treating aged skin and irritations occurring there. The cosmetic product is preferably a barrier-stabilizing lotion or a barrier-stabilizing cream that contains a dry extract obtained from lady's mantle (Alchemilla).

Abstract: A complete nutritional composition comprising polyphenols is provided for reducing the symptoms of allergies originating from food allergens in young children or infants. Preferably the composition modulates the secondary prevention of allergies while not affecting significantly the primary prevention. The composition comprises an apple extract.

Abstract: The present invention relates to the cosmetic use of dedifferentiated plant cells of a plant of the Rosa sp. genus, or of an extract or a lyophilisate of said cells, as an active agent for caring for aged skin or aged hair. It also relates to rose dedifferentiated cells, in particular Lancôme rose dedifferentiated cells.

Abstract: There is provided a process for making a composition suitable for topical application comprising the steps of a) heating at least one fruit and/or vegetable pulp to up to a temperature in the range of about 40° C. to 100° C.; b) mixing between 1 and 40% w/w of a mild base with the heated fruit and/or vegetable pulp. There is also provided a fruit and/or vegetable derived composition suitable for topical application prepared by the above process. There is further provided a fruit and/or vegetable derived composition comprising at least one fruit and/or vegetable-derived pulp and a mild base, said composition having a pH in the range of about 7.5 to about 9.5.

Abstract: The present invention is generally directed to compositions and methods for amelioration chronic renal failure and related symptoms in domestic animals. In one case, the present invention is directed to a composition for the treatment of chronic renal failure in a domestic animal or symptoms related to chronic renal failure. The composition comprises a Fruit- and Vegetable-Based Additive. In another case, the present invention is directed to a composition for the treatment of chronic renal failure in a domestic animal or symptoms related to chronic renal failure. The composition comprises a Cesium and/or Rubidium salt. In another case, the present invention is directed to a composition for the treatment of chronic renal failure in a domestic animal or symptoms related to chronic renal failure. The composition comprises a Dehydrated Domestic Animal Food and a Phosphate Binder.

Abstract: The present invention relates to a composition including a Laurus nobilis leaf extract as an active ingredient, and particularly, to a composition for preventing or treating hangover including the Laurus nobilis leaf extract, a food composition for preventing or relieving hangover including the Laurus nobilis leaf extract, and a method for preparing the composition. Since the composition according to the present invention includes the Laurus nobilis leaf extract, it has a remarkably excellent effect of lowering blood concentrations of alcohol and acetaldehyde. Its hangover-preventing and treating effects were confirmed by behavioral tests, and thus the composition can be widely applied to foods, drugs, or functional health foods which can be effectively used for preventing and treating hangover.

Abstract: The present invention relates to an antihypertensive agent including a boysenberry seed extract as an active ingredient. According to the invention, there can be provided an effective and highly safe antihypertensive agent having antihypertensive effect so that the agent can contribute to the prevention and amelioration of hypertension and having very little risk of side effects even in continuous intake, and a method for producing the antihypertensive agent at low cost and efficiently.

Abstract: The present invention discloses a drug screening method, drugs promoting extracellular matrix protein crosslinking and their applications, the said drug screening method, is used to screen out materials promoting the expression of LOXL1 gene, wherein, the said drug screening method contains the following steps: A, Construct the 2nd generation lentiviral vector used to control the ZsGreen expression by human LOXL 1 gene promoter. B, Infect human fibroblasts with the 2nd generation lentiviral vector, and construct the new human fibroblasts which integrate PLOXL1-ZsGreen components. C, Drug screening: Inoculate the said human fibroblasts integrating PLOXL1-ZsGreen components into culture medium. Add the analyte into the cell culture medium containing human fibroblast cells. After culturing, detect the green fluorescence intensity of these fibroblast cells, then decide if the analyte promotes LOXL1 gene expression by checking if the green fluorescence intensity is increased.

Abstract: Disclosed herein are embodiments of compositions that include a plurality of seed particles of various sizes, which may be desirable for providing the time-release of compounds present in the seed particles. By having compositions with seed particles having a range of sizes, various desirable time-release profiles may be generated by varying the range of sizes of the seed particles and varying the distribution of various sizes.

Abstract: Beta glucan and fulvic acid can be combined in a dietary supplement as a partial substitute or complete replacement for blue green algae and/or brown seaweed and its derivatives. Beta glucans are widely available as derivatives of Brewer's yeast and fulvic acid is widely available as well. These supplements are not subject to the vagaries of weather-influence growing seasons as is the case with blue green algae and brown seaweed. When combined, beta glucan and fulvic acid can provide a less costly dietary supplement than blue green algae and brown seaweed and its derivatives such as fucoidan.

Abstract: The present invention relates to collagen hydrolysate and the use thereof for treating and/or preventing cellulite.

Abstract: A composition containing rose hip flesh or rose hips including the naturally occurring amount of seeds, or a concentrate is enriched with rose hip seeds for reducing and/or alleviating symptoms of inflammatory diseases. A method of preparing the rose hip seeds involves separating the rose hip seeds from the flesh prior to or after drying. Drying is preferably performed below 50° C. with the rose hip seeds then ground into a powder and mixed with a rose hip composition, a concentrate or an extract containing rose hip shells or Rose hips including their naturally occurring amount of seeds providing a product enriched with Rose hips seeds preferably containing at least 50% up to 85%, (by weight) of rose hip seeds. The composition is useful in the prophylaxis, treatment or alleviation of symptoms related to inflammatory diseases, in particular joint diseases, such as arthritis rheumatoid arthritis and/or osteo arthritis.

Abstract: The present invention relates to a composition of skin external application comprising rose extracts and epigallocatechin gallate (EGCG) as effective ingredients, more particularly to a composition of skin external application that contains rose extracts and EGCG, thereby promoting the synthesis of collagen fiber to promote superior skin elasticity and skin wrinkle improvement with long-lasting effect.

Abstract: Compositions and methods for inducing hair growth and improving hair quality utilizing extracts of blackberry in an amount effective to induce hair growth when applied topically to an area of the skin on which hair growth is desired.

Abstract: L-citrulline for treatment of endothelial dysfunction and in particular of erectile dysfunction and a pharmaceutical composition comprising L-citrulline in combination with one or more substances selected from the group consisting of pycnogenol, aqueous extract of Viscum album, NADPH, tetrahydrobiopterin, folic acid and mixtures thereof.

Abstract: A natural soap is made using a herbal medicine decoction. The natural soap includes herbs including lotus roots, lotus leaves, red ginseng, Hippophae rhamnoides leaves and trunk, persimmon leaves, thuja orientalis, ginger, rosemary, black beans, black sesame, aloe, mulberry leaves, Orostachys japonicus, Angelica gigas, green tea, pine needles, mint, pleuropterus multiflorus, blueberry, and Acorus gramineus. A ripening device ripens the herbs in temperatures of 65 to 95° C. for 3 to 15 days, distilled water or soft water is poured onto the herbs, and the herbs mixed with the water are decocted by a decoction maker.

Abstract: Embodiments of the invention relate to fortified food and dietary supplement products which may be administered to produce desirable physiological improvement. In particular, embodiments of the invention relates to the administration of products enhanced with Morinda citrifolia and iridoids.